Filing Details

Accession Number:
0000950170-24-069289
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-05 16:05:20
Reporting Period:
2024-06-04
Accepted Time:
2024-06-05 16:05:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
886744 Geron Corp GERN Pharmaceutical Preparations (2834) 752287752
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1270928 A John Scarlett C/O Geron Corporation
919 E. Hillsdale Blvd, Suite 250
Foster City CA 94404
Chairman, President And Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-06-04 600,000 $2.54 600,000 No 4 M Direct
Common Stock Disposition 2024-06-04 600,000 $4.00 600,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2024-06-04 600,000 $0.00 600,000 $2.54
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2026-02-11 No 4 M Direct
Footnotes
  1. This transaction reflects an exercise and sale of options due to expire on February 11, 2026 and was conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on February 20, 2024.
  2. Option was fully vested.